THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 89 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $4,610,000 | -6.0% | 144,619 | +6.9% | 0.01% | -16.7% |
Q3 2016 | $4,902,000 | +59.5% | 135,265 | -0.1% | 0.01% | +50.0% |
Q2 2016 | $3,073,000 | +43.0% | 135,449 | +18.5% | 0.00% | +33.3% |
Q1 2016 | $2,149,000 | +27.8% | 114,300 | +11.4% | 0.00% | +50.0% |
Q4 2015 | $1,681,000 | +57.5% | 102,583 | +5.7% | 0.00% | +100.0% |
Q3 2015 | $1,067,000 | -15.9% | 97,093 | -0.4% | 0.00% | -50.0% |
Q2 2015 | $1,269,000 | +5.9% | 97,491 | +41.1% | 0.00% | 0.0% |
Q1 2015 | $1,198,000 | +17.2% | 69,071 | +0.9% | 0.00% | +100.0% |
Q4 2014 | $1,022,000 | -35.8% | 68,488 | -0.8% | 0.00% | -50.0% |
Q3 2014 | $1,591,000 | -27.4% | 69,013 | +0.4% | 0.00% | -33.3% |
Q2 2014 | $2,190,000 | – | 68,707 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chescapmanager LLC | 1,157,718 | $17,117,000 | 2.77% |
Baupost Group | 8,735,168 | $129,149,000 | 1.40% |
Orbimed Advisors | 6,219,110 | $91,950,000 | 1.16% |
Rubric Capital Management LP | 550,747 | $8,143,000 | 0.76% |
Cormorant Asset Management, LP | 650,072 | $9,611,000 | 0.37% |
Rock Springs Capital Management LP | 824,018 | $12,183,000 | 0.31% |
Virtus ETF Advisers LLC | 23,148 | $342,000 | 0.18% |
Tekla Capital Management LLC | 298,470 | $4,413,000 | 0.16% |
PEREGRINE CAPITAL MANAGEMENT LLC | 412,594 | $6,100,000 | 0.16% |
NJ State Employees Deferred Compensation Plan | 38,142 | $564,000 | 0.10% |